Alpha-Thalassemia
Rare Disease·MeSH: alpha-Thalassemia
1 drug in development·1 company·1 clinical trial
Drug Pipeline by Phase
Phase 2(1)
| Drug | Company |
|---|---|
| Mitapivat | AGIOS PHARMACEUTICALS, INC. (AGIO) |
Frequently asked questions
How many drugs are in development for Alpha-Thalassemia?
BioSniper tracks 1 drug in development for Alpha-Thalassemia across 1 company.
How many clinical trials target Alpha-Thalassemia?
There are 1 clinical trial targeting Alpha-Thalassemia tracked by BioSniper.
Deep-dive into Alpha-Thalassemia
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis